Lisinopril
Product Images NDC 33358-213

2 FDA label images from Rxchange Co. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 33358-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (57da7501 D1bd 4304 9508 79af23bfd52c 01)

Chemical Structure (57da7501 D1bd 4304 9508 79af23bfd52c 01)
Chemical structure of lisinopril dihydrate showing its molecular composition and arrangement of atoms, including phenyl, amino acid, and carboxyl groups, along with two water molecules of hydration.*
FDA Label Image

Rxchange Co._33358-213-30_20mg (Rxchange Co. 33358 213 30 20mg)

Rxchange Co._33358-213-30_20mg (Rxchange Co. 33358 213 30 20mg)
Lisinopril 20mg tablet bottle label from RxChange Co., NDC 33358-213-30, containing 30 tablets. The label includes the item number, lot number, and expiration date fields, warnings about prescription use, and disposal instructions. The right side panel shows a list of other RxChange Co. products with respective NDCs.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.